Axitinib is a second-generation tyrosine kinase inhibitor and indazole derivative used primarily to treat advanced renal cell carcinoma by selectively inhibiting vascular endothelial growth factor receptors.… Read more









![Chemical structure of (E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F886230-77-9-E-6-Iodo-3-2-pyridin-2-ylethenyl-1-tetrahydro-2H-pyran-2-yl-1H-indazole.png&w=3840&q=75)




![Chemical structure of 2,2'-(1H,1'H-[3,3'-Biindazole]-6,6'-diylbis(sulfanediyl))bis(N-methylbenzamide)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F22-1H1H-33-Biindazole-66-diylbissulfanediylbisN-methylbenzamide.png&w=3840&q=75)
![Chemical structure of 2,2'-Dithiobis[N-methyl-benzamide]](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2527-58-4-22-DithiobisN-methyl-benzamide.png&w=3840&q=75)




![Chemical structure of 2-[(2-Carbamoylphenyl)disulfanyl]benzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2527-57-3-2-2-Carbamoylphenyldisulfanylbenzamide.png&w=3840&q=75)
![Chemical structure of 2-Methylbenzo[d]isothiazol-3(2H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2527-66-4-2-Methylbenzodisothiazol-32H-one.png&w=3840&q=75)


![Chemical structure of 5-Chloro-3-methyl-N-(2-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-6-yl)benzo[b]thiophene-2-sulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F944835-35-2-5-Chloro-3-methyl-N-2-methyl-2349-tetrahydro-1H-pyrido34-bindol-6-ylbenzobthiophene-2-sulfonamide.png&w=3840&q=75)
![Chemical structure of 6-Iodo-3-[2-(pyridin- 2yl)ethyl]-1-(tetrahydro-2H-pyran- 2-yl)-1H-indazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6-Iodo-3-2-pyridin-2ylethyl-1-tetrahydro-2H-pyran-2-yl-1H-indazole.png&w=3840&q=75)















![Chemical structure of N-Methyl-2-[[3-[(1E)-2-(1-oxido-2-pyridinyl)ethenyl]-1H-indazol-6-yl]sulfinyl]-benzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1348044-24-5-N-Methyl-2-3-1E-2-1-oxido-2-pyridinylethenyl-1H-indazol-6-ylsulfinyl-benzamide.png&w=3840&q=75)
![Chemical structure of N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-formyl-indazol-6-yl]sulfanyl]-benzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-Methyl-2-3-1E-2-2-pyridinylethenyl-1-formyl-indazol-6-ylsulfanyl-benzamide.png&w=3840&q=75)
![Chemical structure of N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-hydroxymethyl-indazol-6-yl]sulfanyl]-benzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2607948-75-2-N-Methyl-2-3-1E-2-2-pyridinylethenyl-1-hydroxymethyl-indazol-6-ylsulfanyl-benzamide.png&w=3840&q=75)
![Chemical structure of N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-methyl-indazol-6-yl]sulfanyl]-benzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-Methyl-2-3-1E-2-2-pyridinylethenyl-1-methyl-indazol-6-ylsulfanyl-benzamide.png&w=3840&q=75)


Axitinib is a second-generation tyrosine kinase inhibitor and indazole derivative used primarily to treat advanced renal cell carcinoma by selectively inhibiting vascular endothelial growth factor receptors. This category provides essential reference standards for Axitinib, including pharmacopeial and non-pharmacopeial impurities, degradation products, metabolites, and stable isotope-labelled compounds. These materials are critical in pharmaceutical laboratories for robust impurity profiling, analytical method development, and quality control validation. By providing accurately characterized reference standards, these compounds assist in the precise identification and quantification of impurities in drug substances and finished products, ensuring regulatory compliance and analytical reliability. Stable isotope-labelled versions are specifically used in mass spectrometry to provide high-precision benchmarks in bioanalytical studies and stability testing, helping laboratories maintain consistency, support batch release, and uphold the integrity of forced degradation and method validation workflows.